NHS National Generic Pharmaceuticals Wave 13
Tender Close: 26th July 2021, 13:00. Invitation to offer for NHS National Generic Pharmaceuticals Wave 13 Offer reference number: CM/PHG/17/5532 Period of framework agreement: The total maximum duration of the framework agreement to be no more than 28 months, with an option or options to extend (at the Authority's sole discretion) for a period or periods up to a total of 48 months. Potential periods of call-offs under the framework agreement: Transition (Everolimus) CESW: 1 March 2022 - 30 September 2023 (19 months...
Buyer
NHS England
Value
£710,767,138
Published
21 Jun 2021
Closes
26 Jul 2021
Procurement details
Source
Contracts Finder
Region
London
Procurement method
Open
Category
Goods
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
33600000
Pharmaceutical products
Lots
Lot default NHS National Generic Pharmaceuticals Wave 13
£710,767,138
Tender Close: 26th July 2021, 13:00. Invitation to offer for NHS National Generic Pharmaceuticals Wave 13 Offer reference number: CM/PHG/17/5532 Period of framework agreement: The total maximum duration of the framework agreement to be no more than 28 months, with an option or options to extend (at the Authority's sole discretion) for a period or periods up...
Delivery: East Midlands · United Kingdom, East of England · United Kingdom, Guernsey, Isle of Man, Jersey, London · United Kingdom
Documents
Unlock document linkOpportunity notice on Contracts Finder
21 Jun 2021
Opportunity notice on Contracts Finder
Tender notice · Web page
Document No. 09 - Stability Data Requirements
Not provided
Document No. 09 - Stability Data Requirements
Link
Document No. 00 - Read Me First Document
Not provided
Document No. 00 - Read Me First Document
Link
Document No. 02 - Terms of offer
Not provided
Document No. 02 - Terms of offer
Link
Document No. 07a - Quality control technical sheet
Not provided
Document No. 07a - Quality control technical sheet
Link
Document No. 05a (v) Product Listing and Usage Hospital Only
Not provided
Document No. 05a (v) Product Listing and Usage Hospital Only
Link
Document No. 01 - Invitation to offer covering letter
Not provided
Document No. 01 - Invitation to offer covering letter
Link
Document No. 06 - Form of offer
Not provided
Document No. 06 - Form of offer
Link
Document No. 07b - Guidance for Performing a Pharmaceutical Quality Assessment of Licensed Medicines for the NHS
Not provided
Document No. 07b - Guidance for Performing a Pharmaceutical Quality Assessment of Licensed Medicines for the NHS
Link
Document No. 03 - Framework Agreement and Terms and Conditions
Not provided
Document No. 03 - Framework Agreement and Terms and Conditions
Link
Document No. 04 - Contract technical specification
Not provided
Document No. 04 - Contract technical specification
Link
Document No. 05a (i) Product Listing and Usage Everolimus
Not provided
Document No. 05a (i) Product Listing and Usage Everolimus
Link
Contains public sector information licensed under the Open Government Licence v3.0.